The Successful Management of COVID-19 Patient with Severe ARDS Using Standard Therapy

Abstract

The clinical manifestations of COVID-19 are very diverse. Young patients generally develop mild infection whereas in older age with various comorbidities the mortality rate increases. Since SARS-CoV-2 virus is still relatively new a variety of treatments to manage COVID-19 patients are sought with various treatment effects. Currently there are many antiviral regimens and other drugs as treatment options for COVID-19 but there has been no specific therapy approved by U.S. Food and Drug Administration (FDA). This case report described the incidence of severe-critical ARDS in young patients without comorbid as well as the comparison of successful management of COVID-19 patients with critical manifestations of severe ARDS using standard therapy. This case study compared the clinical and therapeutic similarities and differences in two patients who have successfully recovered from COVID-19 using standard therapy. Both patients were young male with no comorbid. The therapies administered were antivirus anticoagulant antibiotic ventilator steroid and symptomatic therapy corresponding to clinical condition development. Early case detections ventilator use with high PEEP strategy negative liquid balance symptomatic management and sepsis prevention were factors that support the success of therapy.